Discuss about the natural process of aging, women’s bodies transition from childbearing to non-childbearing stages to cessation of fertility known as menopause. For this discussion a case study of a middle-aged female with co-morbidities will be reviewed for presenting factors involving genitourinary disturbances and vasomotor symptoms. This review will provide key assessment laboratory, and pharmaceutical recommendations for individualized care.
Case Study
Patient: a 46-year-old, 230lb, Caucasian woman
Presenting symptoms: Hypertension 150/90, hot flushing, night sweats, genitourinary symptoms for one month. Regular menstrual cycle, LMP was one month ago
Health History: Hypertension, obesity
Gynecological History: ASCUS five years ago
Preventive Health Screening: Annual pap-smears, yearly mammograms
Surgical History: no relevant history
Familial History: breast cancer; no specification to generation
Home Medication: Norvasc 10mg qd and HCTZ 25mg
Patient Evaluation & Diagnostic Testing
The patient was seen in the office for the above symptoms, hot flushing, night sweats and genitourinary symptoms. Patient stated these symptoms have lasted for one month prior to this appointment. The patient denies any other symptoms. After talking to patient, symptoms are severe and are impacting sleep and sex life. The explanation given to the patient is that she may be experiencing perimenopausal symptoms which can occur between the ages of 45-55 years of age. (Rosenthal & Burchum, 2021). The recommendation is to order an FSH, TSH, and estrogen labs on the third day of the menstrual cycle. Rationale for this would be that FSH levels increase trying to make ovaries produce more estrogen, and estrogen levels will be lower than normal, TSH should also be monitored because thyroid issues overlap menopausal symptoms.(National Cancer Institute, 2021). The annual gynecological exam should include an HPV/Pap test because of a prior ASCUS, an HPV infection can reactivate. (National Cancer Institute, 2021). Liver function, kidney, fasting blood sugar, lipid, bone density test and urine analysis should be initiated to rule out urinary tract infection. (Lee et al. 2020). The patient should be encouraged to try non-pharmacological interventions until diagnostic testing is confirmed and the other possible medical conditions are ruled out. These interventions include, limiting caffeine consumption, increasing fruits and vegetables in diet, avoiding alcohol, staying sexually active (can use water soluble lubrication for dryness), and controlling environmental temperatures in sleeping areas. See the medical physician for cardiovascular symptoms (HTN), see a dietician about obesity and meal planning to reduce weight and prevent weight gain.
Gynecological testing
FSH levels: Normal 3-20mL 10-12mL (premenopausal) 30-40mL (menopause)
Estrogen levels: 30 to 400pg/mL premenopausal
TSH levels: 0.4 to 4.0 mU/L
HPV/Pap: HPV (positive or negative result) Pap (normal, abnormal, unsatisfactory results) to rule out possible HPV infection or cervical cell changes
Urine Analysis: to rule out infection
Medication Review and Recommendation
Patient is currently taking Amlodipine (Norvasc) 10mg, HCTZ 25mg which was prescribed by the medical doctor for hypertension. Fluctuating estrogen levels can affect blood pressure by influencing nitric oxide which is responsible for expanding blood vessels and increasing blood flow. Before increasing or adding blood pressure medication, life-style modifications and low dose of estradiol should be considered. (Lee et al. 2020). The patients hot flashes can be directly correlated with obesity and hypertension. (Delgado & Lopez Ojeda, 2021). Hypertension should be corrected before initiating hormone replacement therapy. (Srivaratha & Abramson, 2018)
Medication adherence was evaluated. Recommendations at this time is to manage physical symptoms. For genitourinary symptoms topical estradiol (Estrace) Initial dose: 2 to 4 grams intravaginally once a day for 1 or 2 weeks then gradually reduce to one-half the initial dose over 1 or 2 weeks with evaluation in 3 weeks. If symptoms are controlled a maintenance dose of 1 gram intravaginally 1 to 3 times a week would be indicated. (Drugs.com 2000-2021). Topical application will limit systemic exposure and keep estrogen levels low.
Patient Education and Adverse Side Effects
The patient should be educated about the risk of estradiol (Estrace) like vaginal bleeding, vulvar irritation, increased risk for yeast infections, decrease in urine output, swelling in legs, face or upper extremities, trouble breathing. There are several medical problems that increase this risk with this medication that include hypertension, blood disorders, history of deep vein thrombosis, pulmonary embolism.(Drugs.com, 2000-2021). Patients should be shown how to apply cream correctly with correct dose application to avoid overdose or misuse.
Conclusion
The complexity of genetic, environmental and normal aging processes make symptom management more difficult. A clinician needs to weigh risk to benefit and educate the patient to make an informed decision on possible symptom management.
References
Delgado, B. & Lopez-Ojeda (2021). Estrogen. in statpearls [internet]. Retrieved from https://www.ncbi.nih.gov/books/NBK538260
Drugs.com (2000-2021). Estradiol. Retrieved from https://www.drugs.com
Lee,S., MoonKyoung, C., Yeon, J., Sungwook, C., Hong, S., Kyu, H., Jeon, G., Joo, J., Kim,S., Lee, D., Chae, H., Tak, K. (2020). 2020 menopausal hormone therapy guidelines. Journal of Menopausal Medicine. doi 10.6118/jmm.2000
National Cancer Institute (2021).Breast cancer research. Retrieved from https://www.cancer.gov/types/breast/research
Rosenthal, L. D., & Burchum, J. R. (2021). Lehnes pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
Srivaratha, K., & Abramson, B. (2018). North american menopause society: Hypertension
in menopausal women the effect and role of estrogen. Retrieved from https://menopause.org
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|
